Disclosed herein is a microsphere for delivery to a target area in a patients body. The microsphere contains a mucin-affecting protease loaded therein and is adapted to release the mucin-affecting protease in a sustained manner when exposed to physiological conditions. Also disclosed are pharmaceutical compositions comprising the microspheres and methods of treatment involving the microspheres.

The present invention relates to novel compositions comprising proteolytic enzymes and fining agents as well as methods for the treatment and/or prevention of cancer using these compositions.

A method of preparing a functionalized wheat protein product is provided. The method comprises an enzyme treatment step wherein a wheat protein composition is contacted with a primary enzyme, and optionally with a secondary enzyme. The primary enzyme comprises a protease that is naturally occurring in a fruit.

The present invention relates to novel compositions comprising proteolytic enzymes and fining agents as well as methods for the treatment and/or prevention of cancer using these compositions.

Disclosed are compositions for promoting the breakdown of gluten proteins. In some example embodiments, the composition comprises one or more of papain, bromelain, and actinidin. In some example embodiments, the composition comprises papain, bromelain, and actinidin. In some example embodiments, the ratio of papain to bromelain to actinidin is 1:2:3. In some example embodiments, the composition also comprises a digestive enzyme. In some example embodiments, the composition also comprises a probiotic.